Peroutka Stephen J 4/A
4/A · NeurogesX Inc · Filed Mar 16, 2012
Insider Transaction Report
Form 4/AAmended
NeurogesX IncNGSX
Peroutka Stephen J
Executive V.P. and CMO
Transactions
- Award
Stock Option (right to buy)
2012-03-13+150,000→ 150,000 totalExercise: $0.48From: 2014-03-13Exp: 2022-03-13→ Common Stock (150,000 underlying) - Award
Stock Option (right to buy)
2012-03-13+150,000→ 150,000 totalExercise: $0.48From: 2013-03-13Exp: 2022-03-13→ Common Stock (150,000 underlying)
Footnotes (3)
- [F1]The option grant shares are granted under the 2007 Stock Plan and shall vest as follows: one-hundred percent (100%) of the total number of shares subject to the option grant shall become exercisable on March 13, 2013, subject to the grantee's continued service relationship with the Company.
- [F2]The option grant shares are granted under the 2007 Stock Plan and shall vest as follows: one-hundred percent (100%) of the total number of shares subject to the option grant shall become exercisable on March 13, 2014 or upon the attainment of the Company's milestone; such milestone must be attained by December 31, 2012 or the shares shall not become exercisable until March 13, 2014, subject to the grantee's continued service relationship with the Company.
- [F3]The option grant shares were erroneously filed as a 175,000 share grant on March 15, 2012, when the grant amount is actually 150,000 shares.